What do systematic reviews say?

Testosterone vs placebo

The review found no eligible studies for this question.

• Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
• Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 1030 participants
  Moderate
• Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 786 participants
  Moderate

Testosterone vs PDE5I

• Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 64 participants
  Very low

Testosterone as an add‐on to PDE5I vs PDE5I

• Testosterone replacement in men with sexual dysfunction 2024 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 282 participants
  Low

Summary of findings: insulin detemir vs NPH insulin

• (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 870 participants
  Low
• (Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes… 2020 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 873 participants
  Very low

Short‐acting insulin analogues vs regular human insulin

• Short‐acting insulin analogues versus regular human insulin for adult, non‐pregnant persons with type 2 diabetes… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 2 participants
  Very low
• Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Calcium supplementation for people with overweight or obesity 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surgery vs preoperative pharmacological therapy and surgery

The review found no eligible studies for this question.

• Surgical and non‐surgical interventions for primary and salvage treatment of growth hormone‐secreting pituitary… 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Low glycaemic index (GI) or glycaemic load (GL) diets vs any other diet

The review found no eligible studies for this question.

• Low glycaemic index or low glycaemic load diets for people with overweight or obesity 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Parathyroidectomy vs observation

• Parathyroidectomy for adults with primary hyperparathyroidism 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 195 participants
  Very low

SGLT‐2 inhibitors vs sulphonylureas

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

DPP‐4 inhibitors vs sulphonylureas

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

GLP‐1 analogues inhibitors vs sulphonylureas

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Insulin analogues vs biphasic insulin

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Patient education vs usual care

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Drug dosage reduction vs usual care

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Meglitinides vs sulphonylureas

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Thermal stability and storage of human insulin 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Recombinant human thyrotropin‐aided radioiodine vs radioiodine

• Recombinant human thyrotropin (rhTSH)‐aided radioiodine treatment for non‐toxic multinodular goitre 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 85 participants
  Very low

Summary of findings: insulin detemir vs insulin glargine

The review found no eligible studies for this question.

• (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Screening for type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found